BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38305430)

  • 1. Testicular cancer with small metastatic burden: optimal approach in 2024.
    Yuen KL; Pandit K; Puri D; Yodkhunnatham N; Bagrodia A
    Curr Opin Urol; 2024 May; 34(3):204-209. PubMed ID: 38305430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroperitoneal lymph-node dissection (RPLND) as upfront management in stage II germ-cell tumours: Evaluation of safety and efficacy.
    Nicolai N; Nazzani S; Tesone A; Macchi A; Piva L; Salvioni R; Stagni S; Torelli T; Agostini E; Celso F; Giannatempo P; Procopio G; Avuzzi B; Lanocita R; Cattaneo L; Catanzaro M; Biasoni D
    Tumori; 2023 Aug; 109(4):379-386. PubMed ID: 35915559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy.
    Daneshmand S; Cary C; Masterson T; Einhorn L; Adra N; Boorjian SA; Kollmannsberger C; Schuckman A; So A; Black P; Bagrodia A; Skinner E; Alemozaffar M; Brand T; Eggener S; Pierorazio P; Stratton K; Nappi L; Nichols C; Luo C; Li M; Hu B
    J Clin Oncol; 2023 Jun; 41(16):3009-3018. PubMed ID: 36913642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current controversies on the role of retroperitoneal lymphadenectomy for testicular cancer.
    Mano R; Di Natale R; Sheinfeld J
    Urol Oncol; 2019 Mar; 37(3):209-218. PubMed ID: 30446455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Retroperitoneal Lymph Node Dissection for Seminoma Metastatic to the Retroperitoneum.
    Matulewicz RS; Benfante N; Funt SA; Feldman DR; Carver B; Doudt A; Knezevic A; Sheinfeld J
    J Urol; 2024 Jan; 211(1):80-89. PubMed ID: 37672753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of primary retroperitoneal lymph node dissection in the treatment of stage II seminoma.
    Sigg S; Fankhauser CD
    Curr Opin Urol; 2023 Jul; 33(4):245-251. PubMed ID: 37144886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014.
    Tabakin AL; Shinder BM; Kim S; Rivera-Nunez Z; Polotti CF; Modi PK; Sterling JA; Farber NJ; Radadia KD; Parikh RR; Kim IY; Saraiya B; Mayer TM; Singer EA; Jang TL
    Clin Genitourin Cancer; 2020 Apr; 18(2):e194-e201. PubMed ID: 31818649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of primary retroperitoneal lymph node dissection in stage I and low-volume metastatic germ cell tumors.
    Heidenreich A; Paffenholz P; Nestler T; Pfister D; Daneshmand S
    Curr Opin Urol; 2020 Mar; 30(2):251-257. PubMed ID: 31972635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of miR-371a-3p to predict viable germ cell tumor in patients with pure seminoma receiving retroperitoneal lymph node dissection.
    Konneh B; Lafin JT; Howard J; Gerald T; Amini A; Savelyeva A; Woldu SL; Lewis CM; Jia L; Margulis V; Coleman N; Scarpini C; Frazier AL; Murray MJ; Amatruda JF; Bagrodia A
    Andrology; 2023 May; 11(4):634-640. PubMed ID: 36254623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Retroperitoneal Lymph Node Dissection for Stage II Seminoma: Is Surgery the New Path Forward?
    Tachibana I; Alabd A; Tong Y; Piroozi A; Mahmoud M; Kern SQ; Masterson TA; Adra N; Foster RS; Hanna NH; Einhorn LH; Cary C
    J Clin Oncol; 2023 Aug; 41(23):3930-3938. PubMed ID: 36730902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.
    Stepanian S; Patel M; Porter J
    Eur Urol; 2016 Oct; 70(4):661-667. PubMed ID: 27068395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroperitoneal Lymph Node Dissection in Clinical Stage IIA/B Metastatic Seminoma: Results of the COlogne Trial of Retroperitoneal Lymphadenectomy In Metastatic Seminoma (COTRIMS).
    Heidenreich A; Paffenholz P; Hartmann F; Seelemeyer F; Pfister D
    Eur Urol Oncol; 2024 Feb; 7(1):122-127. PubMed ID: 37438222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer.
    Pearce SM; Golan S; Gorin MA; Luckenbaugh AN; Williams SB; Ward JF; Montgomery JS; Hafez KS; Weizer AZ; Pierorazio PM; Allaf ME; Eggener SE
    Eur Urol; 2017 Mar; 71(3):476-482. PubMed ID: 27234998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robotic-assisted retroperitoneal lymph node dissection for testicular cancer.
    Gereta S; Hung M; Hu JC
    Curr Opin Urol; 2023 Jul; 33(4):274-280. PubMed ID: 37014761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of patients with low-stage nonseminomatous germ cell testicular cancer.
    Stephenson AJ; Sheinfeld J
    Curr Treat Options Oncol; 2005 Sep; 6(5):367-77. PubMed ID: 16107240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer.
    Calaway AC; Einhorn LH; Masterson TA; Foster RS; Cary C
    Eur Urol; 2019 Nov; 76(5):607-609. PubMed ID: 31174891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review.
    Pierorazio PM; Cheaib JG; Patel HD; Gupta M; Sharma R; Zhang A; Tema G; Bass EB
    J Urol; 2021 Feb; 205(2):370-382. PubMed ID: 32915080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary and Postchemotherapy Retroperitoneal Lymphadenectomy for Testicular Cancer.
    Heidenreich A; Paffenholz P; Nestler T; Pfister D
    Oncol Res Treat; 2018; 41(6):370-378. PubMed ID: 29772568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indications, evolving technique, and early outcomes with robotic retroperitoneal lymph node dissection.
    Werntz RP; Pearce SM; Eggener SE
    Curr Opin Urol; 2018 Sep; 28(5):461-468. PubMed ID: 29979235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
    Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
    Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.